06-25 Interview with Anders Murman, CEO of Scandidos FW
06-17 ScandiDos AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2026 CI
05-15 ScandiDos Unveils Delta4 SRS Pro at ESTRO 2026: Setting a New Standard for Stereotactic QA AQ
05-15 ScandiDos AB Unveils Delta4 SRS Pro at ESTRO 2026 CI
05-06 Anders Murman appointed Acting CEO of ScandiDos AQ
05-06 ScandiDos AB Announces CEO Changes CI
03-18 Scandidos Q3 net sales SEK 13.7 mln RE
03-18 ScandiDos AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2026 CI
12-16 ScandiDos AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2025 CI
18/09/25 ScandiDos AB Reports Earnings Results for the First Quarter Ended July 31, 2025 CI
18/09/25 Scandidos Q1 net sales SEK 11.5 million RE
18/06/25 ScandiDos AB Reports Earnings Results for the Full Year Ended April 30, 2025 CI
18/06/25 Scandidos Q4 EBITDA At SEK -0.2 Mln RE
12/03/25 Scandidos Q3 Net Sales SEK 17.7 Mln RE
12/03/25 ScandiDos AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2025 CI
17/12/24 ScandiDos AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2024 CI
21/11/24 ScandiDos Names Madrid Hospital as Reference Center in Spain MT
21/11/24 ScandiDos Expands with New Reference Center in Madrid, Spain AQ
18/09/24 ScandiDos AB Reports Earnings Results for the First Quarter Ended July 31, 2024 CI
18/06/24 ScandiDos AB Reports Earnings Results for the Fourth Quarter Ended April 30, 2024 CI
18/04/24 Successful user meeting in Madrid highlights ScandiDos' innovative solutions AQ
11/04/24 ScandiDos - HemmaHos FW
13/03/24 ScandiDos AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
21/12/23 Affärsvärlden sets a buy recommendation for Scandidos FW
20/12/23 Sweden's ScandiDos Gets Radiation Therapy Device Orders from China; Shares Up MT
No results match your criteria